Mounjaro injections not only help manage type 2 diabetes but also contribute to weight loss. This is due to the unique mechanism of the medication, which enhances satiety, regulates appetite, and prevents blood sugar spikes.
Mounjaro injections contain the active ingredient Tirzepatide, which treats type 2 diabetes and aids in weight loss through the following mechanisms:
Stimulating Insulin Secretion: Tirzepatide increases the sensitivity of beta cells in the pancreas, enhancing insulin secretion in response to blood glucose levels, thereby managing type 2 diabetes.
Improving Insulin Sensitivity: The medication promotes weight loss in individuals with type 2 diabetes, which helps enhance insulin sensitivity and lower blood sugar levels.
Delaying Gastric Emptying: Tirzepatide slows the emptying of food from the stomach, prolonging feelings of fullness and preventing blood sugar spikes.
The active ingredient Tirzepatide acts on GIP and GLP-1 receptors located in the pancreas, gastrointestinal tract, and brain. This action regulates appetite, promotes weight loss, increases insulin sensitivity, and helps treat type 2 diabetes.
Mounjaro injections are prescribed for:
Managing type 2 diabetes.
Weight loss, combined with diet and exercise.
Always use Mounjaro as directed by a physician.
The initial dose is 2.5 mg once weekly for four weeks, then increased to 5 mg once weekly for another four weeks.
The dose may be further increased by 2.5 mg increments, up to 7.5, 10, 12.5, or 15 mg weekly as prescribed.
Do not alter the dosage without medical advice.
Weekly injection days can be adjusted, provided there is a gap of at least three days between doses.
Administer Mounjaro subcutaneously in the abdomen, thigh, or upper arm.
Mounjaro injections can be administered at any time of day, with or without food.
If you miss a weekly dose:
If it has been 4 days or less, take it as soon as you remember, then continue with your usual schedule.
If it has been more than 4 days, skip the missed dose and continue with the next scheduled dose.
Never double the dose to compensate for a missed one.
Ensure at least a 3-day interval between two doses.
Some individuals may experience the following side effects:
Nausea
Diarrhea
Hypoglycemia
Dizziness
Abdominal pain
Indigestion
Constipation
Gas
Heartburn
Hair loss
Side effects usually subside within days to weeks. To alleviate them:
Eat smaller meals and chew slowly.
Avoid fried or fatty foods.
Consume low-fat, water-rich foods like soups.
Avoid lying down after meals.
Going outside in the fresh air in case of nausea.
Mounjaro injections should not be used in:
Individuals allergic to its components.
Children or adolescents under 18 years.
Consult your doctor before using Mounjaro if you have:
Severe digestive issues or delayed gastric emptying (e.g., severe gastroparesis).
A history of pancreatitis.
Diabetic retinopathy.
Are taking other diabetes medications.
Due to potential diarrhea or vomiting, some individuals may experience fluid loss, which can impair kidney function. It is important to stay hydrated while using Mounjaro.
The effects of Mounjaro on pregnancy are not well understood. Consult a doctor before use during pregnancy or when planning to conceive. Contraceptives are recommended during treatment.
It is unclear whether Tirzepatide passes into breast milk. A doctor should evaluate whether to pause breastfeeding or delay Mounjaro treatment.
Consult your physician before combining Mounjaro with other medications, particularly:
Insulin
Other diabetes medications
Oral contraceptive pills
Keep out of reach of children.
Store between 2-8°C.
Do not freeze, and discard if frozen.
Store in its original packaging away from light.
Can be kept at room temperature (below 30°C) for up to 21 days, after which the pen should be discarded.
Do not use if the pen is damaged, or the solution is cloudy, discolored, or contains particles.
One package contains a single pen with four doses.
Monjaro effect begins within hours of the first dose, peaking in 8-72 hours. Some individuals notice increased satiety within 12 hours.
Blood sugar reduction typically starts within the first 4 weeks, with full effects observed after 4-6 months.
Each pen contains four doses.
Each pen contains 2.4 ml.
Inject Mounjaro subcutaneously into the abdomen (at least 5 cm away from the navel), thigh, or upper arm, rotating injection sites weekly.
Mounjaro is available in the following doses:
2.5 mg
5 mg
7.5 mg
10 mg
12.5 mg
15 mg